Subsequent investigations revealed that c9,t11-CLA effectively suppresses the expression of pro-inflammatory factors, chemokines, and ICAM-1 by inhibiting NF-B transcriptional regulation and dampening MAPK signaling pathway activity, thus exhibiting potent anti-inflammatory properties
doi: 10.11477/mf.1416200945 46 NakatomiYMizunoKIshiiAWadaYTanakaMTazawaSet al
This difference is particularly relevant for individuals with malabsorption issues or gastrointestinal concerns, as well as those looking to feel benefits more quicklyoften within hours of treatment
Future research should include controlled dietary parameters, longitudinal follow-up, and microbiome-targeted interventions to better define host-microbe-drug interactions and improve long-term outcomes in the management of obesity and type 2 diabetes
Instead, Aetna is more likely to cover FDA-approved weight loss medications, such as Wegovy or Saxenda